Zobrazeno 1 - 3
of 3
pro vyhledávání: '"NODAGA-NOC"'
Autor:
Katharina Anna Domnanich, Nicholas P. van der Meulen, Cristina Müller, Bernard Ponsard, Renata Farkas, Raffaella M. Schmid, Andreas Türler, Roger Schibli
Publikováno v:
Domnanich, Katharina Anna; Müller, Cristina; Farkas, Renata; Schmid, Raffaella M.; Ponsard, Bernard; Schibli, Roger; Türler, Andreas; van der Meulen, Nicholas P. (2016). 44Sc for labeling of DOTA-and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations. EJNMMI Radiopharmacy and Chemistry, 1(1), p. 8. Springer 10.1186/s41181-016-0013-5
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry, Vol 1, Iss 1, Pp 1-19 (2016)
Ejnmmi Radiopharmacy and Chemistry
Background Recently, 44Sc (T1/2 = 3.97 h, Eβ+ av = 632 keV, I = 94.3 %) has emerged as an attractive radiometal candidate for PET imaging using DOTA-functionalized biomolecules. The aim of this study was to investigate the potential of using NODAGA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44e6afce732d278b4ca4e0d12b16f01
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
https://boris.unibe.ch/93779/1/art%3A10.1186%2Fs41181-016-0013-5.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Domnanich KA; Laboratory of Radiochemistry, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.; Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland., Müller C; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland., Farkas R; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland., Schmid RM; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland., Ponsard B; SCK.CEN, BR2 Reactor, 2400 Mol, Belgium., Schibli R; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.; Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland., Türler A; Laboratory of Radiochemistry, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.; Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland., van der Meulen NP; Laboratory of Radiochemistry, Paul Scherrer Institute, CH-5232 Villigen-PSI, Switzerland.; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2017; Vol. 1 (1), pp. 8. Date of Electronic Publication: 2016 May 05.